美国生物制药公司Tonix(TNXP.US)盘前涨超10%,因上周五美国FDA批准该公司用于治疗慢性疼痛相关症状的药物。
美国生物制药公司Tonix(TNXP.US)盘前涨超10%,因上周五美国FDA批准该公司用于治疗慢性疼痛相关症状的药物。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.